1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Small Intestine Bacterial Overgrowth in Bangladeshi Infants Is Associated With Growth Stunting in a Longitudinal Cohort

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          INTRODUCTION:

          Small intestine bacterial overgrowth (SIBO) is common in children from low-income countries and has been cross-sectionally associated with growth stunting. We sought to determine whether SIBO was associated with poor growth and neurodevelopmental in a longitudinal analysis.

          METHODS:

          We measured SIBO by glucose hydrogen breath test (GHBT) at 18, 52, 78, and 104 weeks of life in a prospective longitudinal birth cohort of Bangladeshi children. Sociodemographic information and measures of enteric inflammation were analyzed as covariates. Diarrheal samples were tested for enteropathogens using polymerase chain reaction. Regression models were created using standardized mean GHBT area under the H 2 curve (AUC) to determine associations with linear growth and cognitive, language, and motor scores on the Bayley-III Scales of Infant and Toddler Development at 2 years. We also investigated associations between GHBT AUC and enteropathogen exposure.

          RESULTS:

          A 1-ppm increase in standardized mean GHBT AUC was associated with a 0.01-SD decrease in length-for-age Z score ( P = 0.03) and a 0.11-point decrease in Bayley language score ( P = 0.05) at 2 years of age in adjusted analysis. Enteroaggregative Escherichia coli, Enteropathogenic Escherichia coli, Giardia, and Enterocytozoon bieneusi were associated with increased GHBT AUC, whereas Clostridium difficile, norovirus GI, sapovirus, rotavirus, and Cryptosporidium were associated with decreased GHBT AUC. None were consistent across all 4 time points.

          DISCUSSION:

          SIBO in the first 2 years of life is associated with growth stunting and decreased language ability in Bangladeshi infants and may represent a modifiable risk factor in poor growth and neurodevelopment in low-income countries.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Maternal and child undernutrition: global and regional exposures and health consequences.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease.

            More than one-fifth of the world's population live in extreme poverty, where a lack of safe water and adequate sanitation enables high rates of enteric infections and diarrhoea to continue unabated. Although oral rehydration therapy has greatly reduced diarrhoea-associated mortality, enteric infections still persist, disrupting intestinal absorptive and barrier functions and resulting in up to 43% of stunted growth, affecting one-fifth of children worldwide and one-third of children in developing countries. Diarrhoea in children from impoverished areas during their first 2 years might cause, on average, an 8 cm growth shortfall and 10 IQ point decrement by the time they are 7-9 years old. A child's height at their second birthday is therefore the best predictor of cognitive development or 'human capital'. To this 'double burden' of diarrhoea and malnutrition, data now suggest that children with stunted growth and repeated gut infections are also at increased risk of developing obesity and its associated comorbidities, resulting in a 'triple burden' of the impoverished gut. Here, we Review the growing evidence for this triple burden and potential mechanisms and interventions that must be understood and applied to prevent the loss of human potential and unaffordable societal costs caused by these vicious cycles of poverty.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

              Objectives: Breath tests (BTs) are important for the diagnosis of carbohydrate maldigestion syndromes and small intestinal bacterial overgrowth (SIBO). However, standardization is lacking regarding indications for testing, test methodology and interpretation of results. A consensus meeting of experts was convened to develop guidelines for clinicians and research. Methods: Pre-meeting survey questions encompassing five domains; indications, preparation, performance, interpretation of results, and knowledge gaps, were sent to 17 clinician-scientists, and 10 attended a live meeting. Using an evidence-based approach, 28 statements were finalized and voted on anonymously by a working group of specialists. Results: Consensus was reached on 26 statements encompassing all five domains. Consensus doses for lactulose, glucose, fructose and lactose BT were 10, 75, 25 and 25 g, respectively. Glucose and lactulose BTs remain the least invasive alternatives to diagnose SIBO. BT is useful in the diagnosis of carbohydrate maldigestion, methane-associated constipation, and evaluation of bloating/gas but not in the assessment of oro-cecal transit. A rise in hydrogen of ≥20 p.p.m. by 90 min during glucose or lactulose BT for SIBO was considered positive. Methane levels ≥10 p.p.m. was considered methane-positive. SIBO should be excluded prior to BT for carbohydrate malabsorption to avoid false positives. A rise in hydrogen of ≥20 p.p.m. from baseline during BT was considered positive for maldigestion. Conclusions: BT is a useful, inexpensive, simple and safe diagnostic test in the evaluation of common gastroenterology problems. These consensus statements should help to standardize the indications, preparation, performance and interpretation of BT in clinical practice and research.
                Bookmark

                Author and article information

                Journal
                Am J Gastroenterol
                Am J Gastroenterol
                AJGAST
                ACG
                The American Journal of Gastroenterology
                Wolters Kluwer (Philadelphia, PA )
                0002-9270
                1572-0241
                January 2022
                25 October 2021
                : 117
                : 1
                : 167-175
                Affiliations
                [1 ]Division of Pediatric Infectious Diseases, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA;
                [2 ]Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA;
                [3 ]Department of Statistics, University of Virginia, Charlottesville, Virginia, USA;
                [4 ]Infectious Diseases Division, the International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh;
                [5 ]Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA;
                [6 ]Department of Engineering Systems and Environment, University of Virginia, Charlottesville, Virginia, USA;
                [7 ]Department of Public Health Sciences University of Virginia, Charlottesville, Virginia, USA;
                [8 ]Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA;
                [9 ]Nutrition and Clinical Services Division, the International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
                Author notes
                Author information
                http://orcid.org/0000-0003-4816-4728
                Article
                AJG-21-1049 00026
                10.14309/ajg.0000000000001535
                8715995
                34693912
                5c244fed-76a9-4ca8-aee5-6ad99715fed2
                Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology

                This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 April 2021
                : 09 September 2021
                Categories
                Article
                Pediatrics
                Custom metadata
                TRUE
                T

                Gastroenterology & Hepatology
                Gastroenterology & Hepatology

                Comments

                Comment on this article